Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

SPY
Is The Rise Of AI Fatigue Beginning To Drive S&P 500 Lower?

Is The Rise Of AI Fatigue Beginning To Drive S&P 500 Lower?...

JNJ
Johnson & Johnson Q2 Adj. EPS $2.90 Beats $2.85 Estimate, Sales $25.310B Beat $25.047B Estimate

Johnson & Johnson Q2 Adj. EPS $2.90 Beats $2.85 Estimate, Sales $25.310B Beat $25.047B Estimate...

JNJ
Johnson & Johnson Raises FY2026 Adj EPS Guidance from $11.45-$11.65 to $11.60-$11.75 vs $11.59 Est; Raises FY2026 Sales Guidance from $100.300B-$101.300B to $100.800B-$101.400B vs $101.022B Est

Johnson & Johnson Raises FY2026 Adj EPS Guidance from $11.45-$11.65 to $11.60-$11.75 vs $11.59 Est; Raises FY2026 Sales Guidance from $100.300B-$101.3...

GMAB
Genmab Reports Q2 DARZALEX Net Sales Of $4.207B, Up 17.6% YoY

Genmab Reports Q2 DARZALEX Net Sales Of $4.207B, Up 17.6% YoY...

UAL
United Airlines Touts More Legroom, Replaces Select Middle Seats With Shared Tables on New Airbus A321XLR

United Airlines Touts More Legroom, Replaces Select Middle Seats With Shared Tables on New Airbus A321XLR...

ORCL
'AI Videos Are Flooding TikTok Shop' - WSJ

'AI Videos Are Flooding TikTok Shop' - WSJ...

MRK
Merck's Phase 3 KEYNOTE‑C93 Trial Evaluating KEYTRUDA Met Primary Endpoint Of Progression-Free Survival For Treatment Of Patients With Mismatch Repair Deficient Advanced Or Recurrent Endometrial Cancer

Merck's Phase 3 KEYNOTE‑C93 Trial Evaluating KEYTRUDA Met Primary Endpoint Of Progression-Free Survival For Treatment Of Patients With Mismatch Repair...

VCIG
Earnings Scheduled For July 15, 2026

Earnings Scheduled For July 15, 2026...

GS
Wells Fargo Maintains Overweight on Goldman Sachs Group, Raises Price Target to $1325

Wells Fargo Maintains Overweight on Goldman Sachs Group, Raises Price Target to $1325...

GOOG
Berkshire Hathaway Chairman Buffett Says He Made Mistake Not Investing In Google; Company Now 'More Likely To Be A Winner' Based On Its Record; Berkshire Owns ~$31B Of Alphabet Shares; Still Like Berkshire's Investment In Apple

Berkshire Hathaway Chairman Buffett Says He Made Mistake Not Investing In Google; Company Now 'More Likely To Be A Winner' Based On Its Record; Berksh...

MSFT
Wells Fargo Maintains Overweight on Microsoft, Lowers Price Target to $625

Wells Fargo Maintains Overweight on Microsoft, Lowers Price Target to $625...

IBM
What's Going on With IBM Stock Wednesday?

What's Going on With IBM Stock Wednesday?...

TRV
Piper Sandler Maintains Overweight on Travelers Companies, Raises Price Target to $389

Piper Sandler Maintains Overweight on Travelers Companies, Raises Price Target to $389...

UNH
UnitedHealth Stock in the Spotlight Ahead of Q2 Earnings Thursday

UnitedHealth Stock in the Spotlight Ahead of Q2 Earnings Thursday...

GOOG
Live On CNBC, Warren Buffett Says He Made A Mistake Not Investing In Google, And The Company Is Now 'More Likely To Be A Winner' Based On Its Record; Berkshire Hathaway, Which Buffett Chairs, Owns ~$31B Of The Stock Of Google's Parent Alphabet; Buffett, Asked Whether He Or Berkshire CEO Greg Abel Was Behind The Alphabet Investment, Says Abel Is 'The Decider' But Neither Does Anything That The Other Disapproves Of; Says He Still Likes Berkshire's Investment In Apple

Live On CNBC, Warren Buffett Says He Made A Mistake Not Investing In Google, And The Company Is Now 'More Likely To Be A Winner' Based On Its Record; ...

UNH
How to Earn $500 a Month From UnitedHealth Stock Ahead of Q2 Earnings

How to Earn $500 a Month From UnitedHealth Stock Ahead of Q2 Earnings...

GS
Keefe, Bruyette & Woods Maintains Market Perform on Goldman Sachs Group, Raises Price Target to $1130

Keefe, Bruyette & Woods Maintains Market Perform on Goldman Sachs Group, Raises Price Target to $1130...

GS
Barclays Maintains Overweight on Goldman Sachs Group, Raises Price Target to $1245

Barclays Maintains Overweight on Goldman Sachs Group, Raises Price Target to $1245...

JPM
Keefe, Bruyette & Woods Maintains Outperform on JPMorgan Chase, Raises Price Target to $384

Keefe, Bruyette & Woods Maintains Outperform on JPMorgan Chase, Raises Price Target to $384...

JPM
Barclays Maintains Overweight on JPMorgan Chase, Raises Price Target to $420

Barclays Maintains Overweight on JPMorgan Chase, Raises Price Target to $420...